4D Molecular Therapeutics, Inc. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
4D Molecular Therapeutics, Inc. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2019 to Q2 2025.
  • 4D Molecular Therapeutics, Inc. Contract with Customer, Liability, Noncurrent for the quarter ending June 30, 2025 was $219K, a 83.4% decline year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $219K -$1.1M -83.4% Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $434K -$888K -67.2% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $1.06M +$85K +8.75% Dec 31, 2024 10-Q 2025-08-11
Q3 2024 $1.28M +$184K +16.8% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.32M +$471K +55.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.32M +$438K +49.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $972K -$104K -9.67% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $1.1M +$95K +9.49% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $847K -$605K -41.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $884K -$877K -49.8% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.08M -$1.42M -56.8% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1M -$2.01M -66.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.45M -$890K -38% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.76M -$9.93M -84.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $2.49M -$10.7M -81.2% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $3.01M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $2.34M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $11.7M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $13.2M -$377K -2.77% Dec 31, 2020 10-K 2022-03-28
Q4 2019 $13.6M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.